<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Apolipoprotein E type e4 allele frequency is not increased in patients with sporadic inclusion-body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Charles</forename><forename type="middle">R</forename><surname>Hardngton</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Janice</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kwok</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Medical Research Council Centre</orgName>
								<orgName type="laboratory">aCambridge Brain Bank Laboratory</orgName>
								<orgName type="institution">University of Cambridge Clinical School</orgName>
								<address>
									<addrLine>Hills Road</addrLine>
									<postCode>CB2 2QH</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">bDepartment of Neuropathology</orgName>
								<orgName type="institution">Addenbrooke&apos;s Hospital</orgName>
								<address>
									<postCode>CB2 2QW</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Apolipoprotein E type e4 allele frequency is not increased in patients with sporadic inclusion-body myositis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">4BA86D30DA349BA7D73C58A09A346DFB</idno>
					<note type="submission">Received 26 August 1994.; revised version received 21 October 1994; accepted 21 October 1994</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Apolipoprotein E</term>
					<term>Inclusion-body myositis</term>
					<term>Alzheimer&apos;s disease</term>
					<term>Tau protein</term>
					<term>Amyloidfl-protein</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The apolipoprotein E ~enotype was determined for 11 patients with sporadic inclusion-body myositis. Seven cases had the genotype e31e3, the other four cases, e31e4. The frequency of the e4 allele in this group of patients (0.182) was not significantly increased compared with elderly controls (0.147; n = 58), in contrast to Alzheimer's disease in which there was a significant increase (0.328; n = 67). The e2 allele wa:~ not found in any of the 11 sporadic inclusion-body myositis patients and its frequency was decreased in Alzheimer's disease. Despite certain pathological similarities that exist between inclusion body myositis and Alzheimer's disease, their association with particular apolipoprotein E genotypes is distinct.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>There are three major alleles of the apolipoprotein E (apoE) gene: e2, e3 and e4 <ref type="bibr" target="#b12">[13]</ref>. The three isoforms encoded by these three alleles differ by single amino acid substitutions at two positions. The most common isoform is apoE3 that has Cys-ll2 and Arg-158. ApoE2 has Cys in both of these positions, while apoE4 has Arg in both.</p><p>A number of recent observations suggest that apoE might contribute to the pathophysiology of Alzheimer's disease <ref type="bibr">(AD)</ref>. A linkage between the apoE, type e4 allele and late-onset sporadic and familial AD <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b23">24]</ref> has now been established in a number of studies. Inheritance of the e4 allele is associated with a decreasing average age of onset of dementia <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b26">27]</ref>. In addition, development of AD is negatively assoc, iated with the presence of the e2 allele <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b27">28]</ref>. ApoE has been found to be associated, immunohistochemically, with senile plaques and extracellular tangles in AD <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b28">29]</ref> and with other types of amyloid deposits <ref type="bibr">[14,2!9]</ref>. Interactions of apoE with both amyloid fl-protein (Ail) <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b28">29]</ref> and tau protein <ref type="bibr" target="#b24">[25]</ref> in vitro have been provided as further evidence that apoE is involved in the pathogenesis of AD. Nevertheless, the pathophysiological role that apoE plays in the development of AD is still unclear. The specificity for the association of particular apoE polymorphisms with AD is not exclusive. The e4 allele has been associated with Lewy body dementia <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b18">19]</ref>, vascular dementia <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b14">15]</ref> and with cardiovascular disease <ref type="bibr" target="#b6">[7]</ref>, although there are contradictory reports on its association with cardiovascular disease <ref type="bibr" target="#b6">[7]</ref>. In contrast, no such association has been found for Parkinson's disease or Huntington's chorea <ref type="bibr" target="#b10">[11]</ref>. The e2 allele is associated with both hyperlipoprotinaemia <ref type="bibr" target="#b12">[13]</ref> and longevity <ref type="bibr" target="#b21">[22]</ref>.</p><p>Sporadic inclusion-body myositis (S-IBM) is a slowly progressive muscle disease. Pathologically it is characterised by variable degrees of inflammation and the presence of rimmed vacuoles in muscle fibres <ref type="bibr" target="#b0">[1]</ref>. Hereditary inclusion-body myopathy comprises a number of different syndromes that are characterised by vacuolation similar to that found in S-IBM but by an absence of inflammation <ref type="bibr" target="#b0">[1]</ref>. The vacuolated muscle fibres in both the sporadic and hereditary disorders accumulate Ail, al-antichymotrypsin and ubiquitin <ref type="bibr" target="#b0">[1]</ref> and also contain cytoplasmic twisted tubulofilaments that can be decorated by antibodies against tau protein <ref type="bibr">[2]</ref>. Furthermore, apoE immunoreactivity is co-localised with both Afl-immunoreactivity and the twisted tubulofilaments found in vacuolated muscle fibres from patients with both sporadic and hereditary forms of the disease <ref type="bibr" target="#b2">[3]</ref>. Thus these disorders are characterized by several pathological features that are found in AD brains. We have sought to determine whether these similarities are influenced by the inheritance of specific apoE alleles as observed in AD.</p><p>Biopsy specimens were obtained from 11 patients with S-IBM, all of whom had vacuolated muscle fibres containing inclusions. Inclusions were identified either by the characteristic twisted tubulofilaments, observed by electron microscopy, or by immunohistochemical reactivity with antibodies against both ubiquitin and phosphorylated tau. The extent of inflammation in these patients varied from sparse, in three cases, to severe. There was no evidence of a family history for the disease in any of the patients and the mean duration of disease was 4.6 _+ 1.3 years (range 1.5-15 years). Frozen brain tissue was used from 67 patients with autopsy-confirmed sporadic AD, and 58 age-matched, non-demented controls with no Alzheimer-type pathology at autopsy <ref type="bibr" target="#b10">[11]</ref>. Genomic DNA was extracted from frozen tissue, following digestion with proteinase K (0.5 mg/ml) at 60°C for 60 min. DNA was amplified by the polymerase chain reaction and the apoE genotype determined using the LiPA apoE kit (Innogenetics NV, Ghent, Belgium) as described by the manufacturer. Pearson îC 2 test, or Fisher's exact test where necessary, was used to compare the distribution of individual alleles with that found in the nondemented control group.</p><p>The allele distribution for S-IBM patients is shown in Table <ref type="table" target="#tab_0">1</ref>. Seven patients with S-IBM had a genotype of e3/e3 and the other four cases, e3/e4. One of the cases with an e4 allele had scanty inflammation, whereas two cases that were homozygous for the e3 allele had limited inflammation. Thus, the variable extent of inflammation that is characteristic for S-IBM <ref type="bibr" target="#b0">[1]</ref> was not associated with the presence of a single e4 allele. Furthermore, the presence of an e4 allele was not associated with duration of disease since the genotypes for two patients that had the disease in excess of 10 years were e3/e4 and e3/e3.</p><p>The apoE allele frequencies in S-IBM patients were compared with those observed in 67 patients with sporadic AD and in 58 non-demented, age-matched controls (Table <ref type="table" target="#tab_0">1</ref>). The e4 allele frequency (0.18) was slightly greater in S-IBM than that observed in the general population (0.147) but did not differ significantly. This was in contrast to the elevated frequency observed in AD (0.328). Although the sample of S-IBM patients was small, none possessed an e2 allele. In AD, there was an under-representation of the e2 allele, as has been reported in other recent studies <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b27">28]</ref>. The frequency of the e2 allele was decreased even after allowing for the increased e4 allele frequency. When only the e2 and e3 alleles were studied, only 4 out of 90 alleles in AD patients (4.4%) ). There were no significant differences in the allele frequencies between S-IBM and controls.</p><p>were e2, compared with 10 out of 89 (10%) in the control group (~2 --2.2, P = 0.138).</p><p>Although the pathological deposits in S-IBM have immunoreactivity profiles similar to those found in the Alzheimer brain <ref type="bibr" target="#b0">[1]</ref>, including the presence of apoEimmunoreactive lesions <ref type="bibr" target="#b2">[3]</ref>, the apoE genotype distribution for patients with these two diseases differs. In AD, there is a positive association with the e4 allele <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b23">24]</ref> and a negative association with the e2 allele <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b27">28]</ref>. In contrast, S-IBM was not associated with any significant increase i~ the e4 allele. It is possible that the presence of the e2 allele may be protective against S-IBM, but a much larger sample size will be necessary to exclude the possibility that this is due simply to the rarity of this particular allele in the general population <ref type="bibr" target="#b6">[7]</ref>.</p><p>Despite a number of pathological features in common between AD and S-IBM <ref type="bibr" target="#b0">[ 1,</ref><ref type="bibr">2]</ref>, any proposed role for apoE in the pathophysiology of each disease would need to be distinct. One difference between the two diseases relates to the localization of the pathological filaments that react with apoE antiserum. In S-IBM, apoE-immunoreactive tubulofilaments occur in the cytoplasm. In AD, however, it is the extracellular Ail deposits and those neurofibrillary tangles which are predominantly extracellular that react with apoE antiserum <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b28">29]</ref>. Neither the tau nor Ail that accumulate in S-IBM have been characterized to the extent to which polymers of these proteins in AD have been. Therefore, the proteins that accumulate abnormally in S-IBM vacuoles may differ from those in AD in such a way that their interaction with specific apoE isoforms is distinct. Tau epitopes have been found in fibre lesions in a range of muscle disorders other than S-IBM <ref type="bibr" target="#b11">[12]</ref>, and this suggests that their accumulation may not be specific for S-IBM. There are conflicting reports on the nature of the tau in these diseases. Whereas the tau protein detected in S-IBM was phosphorylated <ref type="bibr" target="#b2">[3]</ref>, tau found in a variety of other disorders did not react with AT8, a monoclonal antibody dependent upon tau being phosphorylated at serine-202 <ref type="bibr" target="#b11">[12]</ref>, a residue that is abundantly phosphorylated in AD brain <ref type="bibr" target="#b8">[9]</ref>. It will be necessary to determine the exact status of tau protein in S-IBM and other muscle disorders before further comparisons with AD can be made.</p><p>For AD, a hypothesis has been proposed in which apoE3 acts as a cofactor that protects or sequesters small amounts of non-phosphorylated mu, leaving it available for its normal role in rnicrotubule stabilization <ref type="bibr" target="#b17">[ 18,</ref><ref type="bibr" target="#b24">25]</ref>. In this hypothesis, the rate of tau phosphorylation and PHF formation would be decreased in the presence of apoE3 and the lifespan of protected neurons increased. However, we have reported results that are inconsistent with this hypothesis <ref type="bibr" target="#b10">[ 11 ]</ref>. First, the extent of abnormal tau accumulation does not differ between those AD patients who are homozygous for the e3 allele and those who possess an e4 allele. Second, those Lewy body dementia patients, who lack significant tau pathology, are characterized by an e4 allele frequency elevated to an extent similar to that found in AD. These findings :indicate that the e4 allele is not an aetiological factor that can account for tau pathology in AD. Similarly, the data described here provide no evidence to indicate that either apoE3 or apoE4 protect or confer risk with regard to abnormal tau accumulation in muscle fibres in S-IBM.</p><p>The existence of several S-IBM patients who are homozygous for e3 indicates that neither apoE2 nor apoE4 are essential for the development of this disease. Thus, it seems unlikely that presence of the e4 allele predisposes individuals to accumulate the twisted tubulofilaments characteristic of S-IBM. Likewise, apoE4 does hOt seem necessary to account for the abnormal accumulation of Ail or tau epitopes in these patients. The association of AD and S-IBM with diistinct apoE polymorphisms indicates a different role, if any, for apoE in the development of either disease. Further investigation of the interactions between apoE, Ail and tau may shed light on our understanding of the pathogenesis of these two disorders.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc></figDesc><table><row><cell cols="3">Apolipoprotein E allele frequencies</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Patients Mean</cell><cell>No. of</cell><cell cols="3">ApoE allele frequency</cell></row><row><cell></cell><cell>age (SD)</cell><cell>alleles</cell><cell>e2</cell><cell>e3</cell><cell>e4</cell></row><row><cell>S-IBM</cell><cell>62.7 (11.6)</cell><cell>22</cell><cell>0</cell><cell>0.818</cell><cell>0.182</cell></row><row><cell cols="2">Controls 78.1 (7.7)</cell><cell>116</cell><cell>0.086</cell><cell>0.767</cell><cell>0.147</cell></row><row><cell>AD</cell><cell cols="2">77.8 (10.2) 134</cell><cell cols="3">0.030* 0.640** 0.328***</cell></row><row><cell cols="6">The distribution of individual alleles in AD was compared with that</cell></row><row><cell cols="6">found in the non-demented control group (*Z2=3.73. P=0.053;</cell></row><row><cell cols="5">**X2=4.66, P=0.031, **'2'2=11.14, P&lt;0.001</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This work was supported by the Leopoid Müller Estate.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">New advances in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opinion Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion body myositis muscle resemble paired helieal filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreactive deposits in inclusion-body muscle disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="page" from="364" to="365" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<author>
			<persName><forename type="first">R</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Edwardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Mckeith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Ince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Apolipoprotein E genes in Lewy body and Parkinson&apos;s disease</title>
				<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="page">1565</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Corder</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">A M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gaskell</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Rimmler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Locke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Conneally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Schmader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Haines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pericak-Vance</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="180" to="184" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&apos;s disease in late onset families</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Corder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gaskell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Sm~di</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Haines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pericak-Vance</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="page" from="921" to="923" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Davignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Gregg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Sing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Apolipoprotein E polymorphism and atheroselerosis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="21" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note>Arterioselerosis</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Apolipoprotein E e4 allele in Alzheimer&apos;s disease and vaseular dementia</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Frisoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Calabresi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geroldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bianehetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>D'acquarica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Govoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Sirtori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trabucchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Franceschini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dementia</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="240" to="242" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The abnormal phosphorylation of tan protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Crowther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Six</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lübke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vandermeeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci. USA</title>
				<meeting>Natl. Acad. Sci. USA</meeting>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="5066" to="5070" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">ApoE genotype and Down&apos;s syndrome, Laneet</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Crook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raghaven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page" from="979" to="980" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The influence of apolipoprotein E genotype on senile dementia of the Alzheimer-and Lewy body-types: significance for etiological theories of Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Louwagie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rossau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vanmechelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Xuereb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">C M</forename><surname>Wischik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Microtubule-associated protein tau epitopes are present in fiber lesions in diverse muscle disorders</title>
		<author>
			<persName><forename type="first">U</forename><surname>Lübke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Six</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Villanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vandermeeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ceuterick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-J</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="175" to="188" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: cholesterol transport protein with expanding role in cell biology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="page" from="622" to="630" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer&apos;s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Namba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomonawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kawasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Otomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">541</biblScope>
			<biblScope unit="page" from="163" to="166" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Apolipoprotein E genotype and Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Murukami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yamada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page">737</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Apolipoprotein E polymorphism and Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Poirier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Davignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bouthillier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bertrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gauthier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page" from="687" to="689" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Apolipoprotein E in sporadic Alzheimer&apos;s disease: allelic variation and receptor interactions</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Rebeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Reiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Hyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="575" to="580" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Apolipoprotein E affects the rate of Alzheimer&apos;s disease expression: fl-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="429" to="437" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Apolipoprotein E e4 allele frequency in patients with Lewy body dementia, Alzheimer&apos;s disease and age-matched controis</title>
		<author>
			<persName><surname>St</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Clair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Norrman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wilcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brookes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="45" to="46" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Apolipoprotein E associates with fl-amyloid peptide of Alzheimer&apos;s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Sanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mahley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Frangione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="860" to="869" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Apolipoprotein E e4 allele distributions in late-onset Alzheimer&apos;s discase and in other amyloid-forming diseases</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schmader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C S</forename><surname>Breitner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Goldfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Manwering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Szymanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mccown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Dole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perieak-Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">l.amcet</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page">7100711</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genetic associations with C.R. Harrin gton et aL I</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schächter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Faure-Delanef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guénot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rouger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Froguel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lesueur-Ginot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroscience Letters</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="29" to="32" />
			<date type="published" when="1994">1995. 1994</date>
		</imprint>
	</monogr>
	<note>Nature Genet.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">lnereased amyloid fl-peptide deposition in eerebral eortex as a eonsequence of apolipoprotein E genotype in lateonset Alzheimer disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Sehmeehel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Crain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hulette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Joo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Perieak-Vanee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proe. Natl. Aead. SeL USA</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="9649" to="9653" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: high avidity binding to fl-amyloid and inereased frequeney of type 4 allele in late-onset familial Alzheimer disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sehmeehel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pedeak-Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Enghild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Salvesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proe. Natl. Aead. SeL USA</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1977" to="1981" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Hypothesis: micmtubule instability and paired helical filament formation in the Alzheimcr disease braln are related to apolipoprorein E genotype</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Corder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L.-M</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Alberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hulette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Einstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Sehmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pedeak-Vanee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="163" to="171" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Protection against Alzheimer&apos;s disease with almE e2</title>
		<author>
			<persName><forename type="first">C</forename><surname>Talbot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lendon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Craddoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shears</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Mords</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goate</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Laneet</title>
		<imprint>
			<biblScope unit="page" from="1432" to="1433" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Apolipoprorein E: risk factor for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M.-S</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Tangalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Schaid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kokmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ivnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Thibodeau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="643" to="649" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Frequeney of the apolipoprotein E e2 allele is diminished in sporadie Alzheimer disease</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Rebeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Hyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosei. Lett</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="46" to="48" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Apolipoprotein E: a pathologieal chapemne protein in patients with cerebral and systemic amyloid</title>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Frangione</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosei. Lett</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="235" to="238" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
